DZ Bank
CHRS icon

DZ Bank’s Coherus Oncology CHRS Stock Holding History

DZ Bank’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Hold
159,990
– – ﹤0.01% 908
2026
Q1 		$270K Buy
+159,990
New +$284K ﹤0.01% 867
2022
Q2 		– Sell
-51,145
Closed -$660K – 1027
2022
Q1 		$660K Sell
51,145
-269,537
-84% -$3.43M ﹤0.01% 774
2021
Q4 		$5.24M Buy
320,682
+130,281
+68% +$2.28M ﹤0.01% 602
2021
Q3 		$3.06M Buy
+190,401
New +$2.79M ﹤0.01% 567

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

DZ Bank's CHRS Position: Q2 2026 in Review

DZ Bank held its Coherus Oncology (CHRS) position steady in Q2 2026 at 159,990 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #908.

DZ Bank first reported a position in CHRS in Q3 2021 and has held it in 5 quarters since. The position peaked at $5.24M in Q4 2021. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • DZ Bank held 159,990 shares of Coherus Oncology worth $224K as of Q2 2026.
  • DZ Bank left its Coherus Oncology share count unchanged in Q2 2026.
  • Coherus Oncology made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #908 holding.
  • DZ Bank first reported a position in Coherus Oncology in Q3 2021 and has held it in 5 quarters since.
  • DZ Bank's Coherus Oncology position peaked at $5.24M in Q4 2021.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.